Cardiovascular disease (CVD) is the leading cause of death globally and even in developed nations poses a significant health, social and economic burden. More than 10% of the UK population (7.6 million) live with CVD, with an estimated prevalence that is double that of Alzheimer’s disease and cancer combined1.
CVD has been identified as a key target by the UK government, Public Health England, NHS England and NHS Improvement. In an effort to tackle CVD, the NHS Long Term Plan has created specific targets in reduction of mortality through CVD risk prevention, with guidance on the importance of collaborative action between stakeholders. COVID-19 has undoubtedly caused huge disruptions in healthcare delivery; however, the front against CVD remains united and lessons have been learnt through the management of this pandemic. With growing support from national organisations, there are reasons for optimism.
As we emerge from the pandemic there is the challenge of dealing with its wider impact on health but also an opportunity to embrace new ways of working2.
During this patient case-based webinar you will have the opportunity to explore the central aims of the NHS Long Term Plan to improve CVD prevention and management, with the goal of improving quality of care for patients at risk of CV events.
Based on recent literature, we now have a better understanding of the impact of atrial fibrillation on morbidity and mortality, relevant to CVD and renal disease. 3 As such, this webinar will look at the practical implementation of the guidelines in a holistic way implementing the Detect, Protect and Perfect national agenda on Stroke prevention in Atrial Fibrillation.
2. https://ukhsa.blog.gov.uk/2021/02/12/cardiovascular-disease-building-back-better/
3. Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 2016;354:i4482. https://doi.org/10.1136/bmj.i4482
Dr Jim Moore Dr Moore is a GP in Gloucestershire with a special interest in Cardiovascular Medicine and President of the Primary Care Cardiovascular Society since 2019, spearheading significant changes in this organisation which currently has 3,500 members. He lectures extensively across the UK.
He has been heavily involved in National CVD advisory groups, guidelines and working parties. He is currently a member of the National Heart Failure Audit Expert Steering Group. He was a member of the NICE Chronic Heart Failure in Adults Guideline committee (2016-2018) and was a board member of British Society for Heart Failure.
Dr Moore has provided cardiovascular clinical support to local commissioning organisations for over two decades and more recently to Cardiac Networks in the South-West. He is currently Clinical Co-Lead (Primary Care) for the West of England Integrated Cardiac Clinical Network.
Dr Moore is the National Clinical Co- Lead (Primary Care) for the National Cardiac Transformation Programme and also provides support for the National Cardiovascular Prevention Programme.
He has been involved in the establishment and subsequent development of the community-based Gloucestershire Heart Failure service since its inception in 2003 where he continues to work as a GPSI.
Dr Chris Arden Chris Arden is a GP near Winchester, Hampshire. He also works in
community cardiac clinics in Southampton and Winchester as a GPSI in
cardiology, assessing patients with suspected heart failure, atrial
fibrillation, palpitations, hypertension and valvular heart disease.
The community cardiac service provides echocardiography, ambulatory
ECG, blood pressure and event recorder monitoring; receiving consultant mentorship
support from secondary care and working in partnership with specialist heart failure and
cardiac rehabilitation nursing colleagues. He does a weekly stress echo clinic at Southampton General Hospital and has BSE
accreditation in echocardiography.Chris Arden is Former Editor-in-Chief of the Primary Care Cardiovascular Journal, a
member of the Primary Care Cardiovascular Society, British Society of Echocardiography,
British Society of Heart Failure and British Heart Valve Society.
He is on the editorial board of the British Journal of Cardiology.
This webinar will NOT be recorded due to the presentation being the Intellectual Property of the speakers.
The Zoom link to join the event will be emailed to the email address you booked with. This may be received into your spam/junk inboxes, please check.
If you cannot locate the Zoom link, please email webinar@mediconf.co.uk for assistance.
We no longer offer the option to dial in using your phone due to the excessive fees charged.
Find us on LINKEDIN
© Copyright 2007 - 2026 MediConf ©, Inc. All Rights Reserved ©
Registered Office: MediConf Uk c/o LCW Consulting, SWP, Suffolk House, George Street, Croydon, Surrey, CR0 0YN
Registered in England No. 09705397. Company registered in England and Wales. VAT Registration Number: 219014242
Telephone: 01444 414 264
Website design & development by Dual Media Ltd
This site is intended for use by UK healthcare professionals.
Please select the appropriate option below.